Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Inflammation in response to n3 fatty acids in a porcine obesity model.

Faris RJ, Boddicker RL, Walker-Daniels J, Li J, Jones DE, Spurlock ME.

Comp Med. 2012 Dec;62(6):495-503.

2.

Absence of Tlr2 protects against high-fat diet-induced inflammation and results in greater insulin-stimulated glucose transport in cultured adipocytes.

Davis JE, Braucher DR, Walker-Daniels J, Spurlock ME.

J Nutr Biochem. 2011 Feb;22(2):136-41. doi: 10.1016/j.jnutbio.2009.12.008.

PMID:
20434320
3.

The c-Jun N-terminal kinase mediates the induction of oxidative stress and insulin resistance by palmitate and toll-like receptor 2 and 4 ligands in 3T3-L1 adipocytes.

Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME.

Horm Metab Res. 2009 Jul;41(7):523-30. doi: 10.1055/s-0029-1202852. Epub 2009 Mar 10.

PMID:
19277946
4.

Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat.

Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME.

Obesity (Silver Spring). 2008 Jun;16(6):1248-55. doi: 10.1038/oby.2008.210. Epub 2008 Apr 10.

5.

Differential regulation of EphA2 in normal and malignant cells.

Walker-Daniels J, Hess AR, Hendrix MJ, Kinch MS.

Am J Pathol. 2003 Apr;162(4):1037-42. Review. No abstract available.

6.

c-Cbl-dependent EphA2 protein degradation is induced by ligand binding.

Walker-Daniels J, Riese DJ 2nd, Kinch MS.

Mol Cancer Res. 2002 Nov;1(1):79-87.

7.

Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase.

Zelinski DP, Zantek ND, Walker-Daniels J, Peters MA, Taparowsky EJ, Kinch MS.

J Cell Biochem. 2002;85(4):714-20.

PMID:
11968011
8.

MCF-10A-NeoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancer.

Zantek ND, Walker-Daniels J, Stewart J, Hansen RK, Robinson D, Miao H, Wang B, Kung HJ, Bissell MJ, Kinch MS.

Clin Cancer Res. 2001 Nov;7(11):3640-8.

9.

TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1.

Fenrick R, Wang L, Nip J, Amann JM, Rooney RJ, Walker-Daniels J, Crawford HC, Hulboy DL, Kinch MS, Matrisian LM, Hiebert SW.

Mol Cell Biol. 2000 Aug;20(16):5828-39.

10.

Overexpression of the EphA2 tyrosine kinase in prostate cancer.

Walker-Daniels J, Coffman K, Azimi M, Rhim JS, Bostwick DG, Snyder P, Kerns BJ, Waters DJ, Kinch MS.

Prostate. 1999 Dec 1;41(4):275-80.

PMID:
10544301
11.

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search.

Smith JR, Freije D, Carpten JD, Grönberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM, Isaacs WB.

Science. 1996 Nov 22;274(5291):1371-4.

PMID:
8910276

Supplemental Content

Loading ...
Support Center